|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.357
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.292
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.263
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.202
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.178
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.176
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.173
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.167
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.167
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.163
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.162
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.162
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.158
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.149
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.146
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.141
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.139
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.137
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.137
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.132
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.128
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.127
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.122
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.121
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.119
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.118
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.116
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.115
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.109
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.105
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.101
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.099
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.099
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.097
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.093
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.088
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.083
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.082
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.081
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.080
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.080
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.079
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.079
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.076
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.075
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.075
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.074
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.074
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.073
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.073
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.073
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.073
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.073
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.072
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.071
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.070
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.069
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.067
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.066
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.065
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.064
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.063
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.062
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.061
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.061
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.060
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.060
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.059
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.058
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.058
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.058
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.057
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.057
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.056
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.055
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.055
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.055
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.055
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.054
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.054
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.054
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.054
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.054
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.053
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.052
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.052
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.052
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.051
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.051
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.050
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.050
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.050
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.049
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.049
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.048
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.047
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.047
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.047
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.045
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.045
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.045
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.044
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.044
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.044
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.043
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.043
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.043
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.042
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.042
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.041
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.041
|
|
|
|
mitochondrion transport along microtubule
|
GO:0047497 |
3 |
0.040
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.040
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.040
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.040
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.040
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.039
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.039
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.039
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.039
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.039
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.039
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.039
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.039
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.038
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.038
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.038
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.038
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.038
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.038
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.037
|
|
|
|
memory
|
GO:0007613 |
58 |
0.037
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.036
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.036
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.036
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.036
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.035
|
|
|
|
centrosome separation
|
GO:0051299 |
4 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.035
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.034
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.034
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.034
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.033
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.033
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.033
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.033
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.033
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.032
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.032
|
|
|
|
negative regulation of glycoprotein metabolic process
|
GO:1903019 |
3 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.032
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.031
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.031
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.031
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.031
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.031
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.031
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.031
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.030
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.030
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.030
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.030
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.030
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.030
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.030
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.030
|
|
|
|
golgi to endosome transport
|
GO:0006895 |
3 |
0.029
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.029
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.029
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.029
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.029
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.029
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.029
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.029
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.029
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.029
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.028
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.028
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.028
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.028
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.028
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.028
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.028
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.028
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.028
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.027
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.027
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.027
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.027
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.027
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.027
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.027
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.026
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.026
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.026
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.026
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.026
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.026
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.026
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.026
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.025
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.025
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.025
|
|
|
|
mitochondrial genome maintenance
|
GO:0000002 |
15 |
0.025
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.025
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.025
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.025
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.025
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.025
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.025
|
|
|
|
heart field specification
|
GO:0003128 |
6 |
0.025
|
|
|
|
regulation of cytoplasmic translation
|
GO:2000765 |
4 |
0.025
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.025
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.025
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.024
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.024
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.024
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.024
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.024
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.024
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.024
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.024
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.024
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.024
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.023
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.023
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.023
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.023
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.023
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.023
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.023
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.023
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.023
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.023
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.023
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.023
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.023
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.022
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.022
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.022
|
|
|
|
regulation of n methyl d aspartate selective glutamate receptor activity
|
GO:2000310 |
10 |
0.022
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.022
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.022
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.022
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.022
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.022
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.022
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.022
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.021
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.021
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.021
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.021
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.021
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.021
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.021
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.021
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.021
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.021
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.021
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.021
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.020
|
|
|
|
inositol phosphate mediated signaling
|
GO:0048016 |
13 |
0.020
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.020
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.020
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.020
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.020
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.020
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.020
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.019
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.019
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.019
|
|
|
|
synapsis
|
GO:0007129 |
34 |
0.019
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.019
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.019
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.019
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.019
|
|
|
|
positive regulation of fear response
|
GO:1903367 |
1 |
0.019
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.019
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.019
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.019
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.019
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.019
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.019
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.018
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.018
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.018
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.018
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.018
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.018
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.018
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.018
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.018
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.018
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.018
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.018
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.018
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.018
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.018
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.017
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.017
|
|
|
|
mitochondrion localization
|
GO:0051646 |
9 |
0.017
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.017
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.017
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.017
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.017
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.017
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.017
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.017
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.017
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.017
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.017
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.017
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.017
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.017
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.017
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.016
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.016
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.016
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.016
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.016
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.016
|
|
|
|
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002823 |
23 |
0.016
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.016
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.016
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.016
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.016
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.016
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.016
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway
|
GO:0043162 |
3 |
0.016
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.016
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.016
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.016
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.016
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.016
|
|
|
|
regulation of mrna polyadenylation
|
GO:1900363 |
1 |
0.016
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.016
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.016
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.016
|
|
|
|
positive regulation of endoplasmic reticulum stress induced intrinsic apoptotic signaling pathway
|
GO:1902237 |
3 |
0.016
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.016
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.016
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.016
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.016
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.016
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.016
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.016
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.015
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.015
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.015
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.015
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.015
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.015
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.015
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.015
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.015
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.015
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.015
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.015
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.015
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.015
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.015
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.015
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.015
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.015
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.015
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.015
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.015
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.015
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.015
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.015
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.015
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.015
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.014
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.014
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.014
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.014
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.014
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.014
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.014
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
|
regulation of ran protein signal transduction
|
GO:0032015 |
3 |
0.014
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.014
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.014
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.014
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.014
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.014
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.014
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.014
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.014
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.014
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.014
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.014
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.014
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.014
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.014
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.014
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.014
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.014
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.013
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.013
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.013
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.013
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.013
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.013
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.013
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.013
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.013
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.013
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.013
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.013
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.013
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.013
|
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.013
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.013
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.013
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.013
|
|
